I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Panretinal Photocoagulation (PRP) Laser for Diabetic Eye Disease
Understanding Panretinal Photocoagulation
PRP is a focused laser treatment designed to slow or stop the growth of abnormal blood vessels that develop in advanced diabetic eye disease. It works by targeting the outer areas of the retina, the light-sensitive tissue that lines the back of the eye.
PRP uses a concentrated beam of laser light to create hundreds or even thousands of tiny, controlled burns in the peripheral retina. The peripheral retina is the outer ring of retinal tissue, away from the center. Each burn is extremely small, roughly the size of a pencil tip. This carefully applied laser energy triggers changes inside the eye that help stop dangerous blood vessel growth before it causes severe vision loss.
PRP has been the standard treatment for proliferative diabetic retinopathy since the 1970s and remains one of the most effective tools available for preserving vision in people with advanced diabetic eye disease.
In advanced diabetic eye disease, areas of the peripheral retina stop receiving enough blood flow. When these tissues are starved of oxygen, they release chemical signals, including a protein called vascular endothelial growth factor, or VEGF. VEGF triggers the growth of new, fragile blood vessels on the surface of the retina. These abnormal vessels are prone to bleeding and can cause serious complications.
PRP works by applying laser energy to create controlled burns in these oxygen-starved areas. Green, yellow, or red wavelengths of laser light may be used. The burns reduce the amount of retinal tissue that needs oxygen. With lower oxygen demand, the eye produces less VEGF, and the abnormal blood vessels shrink or stop growing. In practical terms, PRP trades some peripheral vision to protect the central vision needed for reading, driving, and recognizing faces.
PRP is primarily used for proliferative diabetic retinopathy (PDR), the most advanced stage of diabetic eye disease. At this stage, new blood vessels grow on the surface of the retina or the optic nerve. Because these vessels are fragile, they can bleed into the vitreous, the gel-like fluid that fills the eye. They can also form scar tissue that pulls on the retina, potentially causing a retinal detachment, which is a serious sight-threatening emergency.
Retina specialists may also recommend PRP for severe non-proliferative diabetic retinopathy (NPDR) when there is a high risk of progression to PDR. The American Academy of Ophthalmology supports PRP for PDR with high-risk features and recommends consideration of early PRP in appropriate patients with severe NPDR.
Who Needs PRP?
Not everyone with diabetes will develop proliferative diabetic retinopathy, but the risk increases significantly over time. Understanding who is most likely to need PRP can help patients stay ahead of complications through regular monitoring and early care.
PRP is recommended for people whose diabetic eye disease has progressed to the proliferative stage, meaning new abnormal blood vessels have begun growing on the retina or optic nerve. People who have had diabetes for many years, or whose blood sugar has been difficult to control, face the greatest risk of reaching this stage. Research has shown that a meaningful percentage of people diagnosed with diabetes at a young age eventually require PRP, compared to a lower rate among those diagnosed later in life.
Several factors increase the likelihood that diabetic eye disease will progress to the point where PRP becomes necessary. Knowing these can help guide how closely you are monitored over time.
- Long duration of diabetes, particularly over 10 years
- Poor blood sugar control, reflected by a high HbA1c level
- High blood pressure that is not well managed
- Diabetic kidney disease, which signals widespread blood vessel damage throughout the body
- Pregnancy in people with diabetes, which can accelerate retinopathy progression
- Type 1 diabetes, which carries a higher rate of PDR compared to type 2 diabetes
Treating PDR before serious complications develop gives PRP the best chance of preserving vision. Once a vitreous hemorrhage (bleeding inside the eye) or a tractional retinal detachment has occurred, treatment becomes more complex and outcomes become less predictable. A retina specialist will monitor the retina with regular dilated exams and advanced imaging to determine the right time to begin PRP, with the goal of catching disease changes as early as possible.
Warning Signs to Watch For
Diabetic eye disease can advance quietly for a long time before symptoms appear. Knowing when to seek urgent care can make the difference between preserving vision and losing it.
In many cases, proliferative diabetic retinopathy causes no noticeable symptoms in its earliest stages. Vision may appear completely normal even as dangerous new blood vessels are forming on the retina. This is one of the most important reasons why regular dilated eye exams are essential for anyone living with diabetes. A retina specialist can detect these changes with examination and imaging before you notice anything wrong.
Certain symptoms may signal a serious complication such as vitreous hemorrhage or retinal detachment. If you notice any of the following, contact a retina specialist immediately or go to an emergency room right away.
- A sudden increase in floaters, especially dark spots or cobweb-like shapes in your vision
- Flashes of light, particularly in the peripheral (side) vision
- A curtain-like shadow or dark area blocking part of your visual field
- Sudden, significant loss of vision in one eye
- Severe eye pain or redness
These symptoms do not always mean the worst has occurred, but they should never be ignored. Prompt evaluation and early treatment for these complications can make a significant difference in how much vision can be preserved.
How We Diagnose and Plan PRP Treatment
Before recommending PRP, our specialists perform a careful evaluation using both clinical examination and advanced imaging. This helps ensure that treatment is precisely targeted and thoughtfully planned for each patient.
The first step is a thorough dilated eye exam. Drops are placed in the eye to widen the pupil, allowing a detailed view of the retina, optic nerve, and blood vessels inside the eye. Your specialist looks carefully for signs of neovascularization (the medical term for new abnormal blood vessel growth), hemorrhages, and other changes that indicate PDR or high-risk NPDR.
Several types of imaging help guide our treatment decisions. Fluorescein angiography involves injecting a safe yellow dye into a vein in the arm. A specialized camera then photographs the dye as it moves through the retinal blood vessels, revealing areas of poor blood flow, leaking vessels, and abnormal new vessel growth in high detail.
Optical coherence tomography, or OCT, uses light waves to create detailed cross-sectional images of the retina. OCT helps us assess the macula, the central area of the retina responsible for sharp, detailed vision. If macular edema (swelling in the macula) is present, it may need to be treated separately or alongside PRP. Wide-field imaging can also provide a broader view of the peripheral retina and help identify areas most at risk.
Based on exam findings and imaging results, your retina specialist will determine whether PRP is needed and how urgently treatment should begin. The plan will outline how many laser sessions may be required, whether anti-VEGF injections should be included, and the expected timeline. Every plan is built around the individual patient's eye health and overall medical situation.
How PRP Is Performed
PRP is performed in our office and does not require a hospital or operating room. Our specialists use modern laser technology to deliver treatment as comfortably and efficiently as possible.
Before the procedure begins, numbing eye drops are applied to minimize discomfort. The pupil is then dilated with drops to give the specialist a wide view of the peripheral retina. A special contact lens is placed on the surface of the eye to focus the laser beam and keep the eyelids comfortably open during the session.
Your retina specialist uses a slit-lamp microscope equipped with a laser delivery system to precisely apply laser energy to the peripheral retina. Current protocols typically involve 1,200 to 1,600 laser burns, with spot sizes ranging from 200 to 500 microns, delivered over two to four sessions. Each pulse creates a small, controlled burn that begins the process of reducing oxygen demand in the treated retinal tissue.
Most patients describe a stinging or deep aching sensation during treatment, and the level of discomfort varies from person to person. Modern pattern-scanning laser systems deliver multiple laser spots in rapid sequence with shorter pulse durations, around 20 milliseconds compared to the traditional 100 milliseconds. This technology has meaningfully reduced both pain and treatment time while maintaining clinical effectiveness.
A single PRP session typically involves 15 to 30 minutes of active laser time. With preparation and recovery, a complete visit usually takes about one hour. Splitting treatment across multiple sessions allows each area of the retina time to respond and heal between visits, and reduces the risk of side effects such as swelling or a temporary rise in eye pressure.
Our practice uses advanced laser platforms including navigated laser systems, which use retinal imaging to guide laser placement with high precision, and multispot pattern lasers, which can deliver a grid of laser spots in a fraction of a second. These advances allow for faster, more accurate treatment and greater patient comfort compared to older single-spot laser techniques.
Recovery and What to Expect After PRP
Most patients tolerate PRP well and return to their normal routines within a day or two. Knowing what is normal after treatment helps you recognize what to watch for and when to reach out to us.
Immediately following a PRP session, your vision will likely be blurry for several hours due to the dilating drops and the bright laser light used during the procedure. Some patients experience mild aching around the eye or a headache, both of which typically resolve within a day. Because vision will be temporarily impaired, please arrange for someone to drive you home after your appointment.
The full effect of PRP develops gradually over weeks to months as the abnormal blood vessels shrink and the retina heals. During this time, it is common to notice some changes in peripheral vision and night vision. These changes are expected because PRP intentionally treats peripheral retinal tissue to reduce its oxygen demand and suppress abnormal vessel growth.
Central vision is typically preserved or stabilized. The landmark Diabetic Retinopathy Study, conducted with support from the National Eye Institute, found that PRP reduces the risk of severe visual loss by more than 50 percent in patients with high-risk PDR. At two years, treated eyes developed severe visual loss at roughly half the rate of untreated eyes, and the protective benefit continued to grow over four years of follow-up. These findings established PRP as a cornerstone of PDR treatment.
PRP is generally well tolerated, but side effects can occur. Understanding what to expect helps you know what is a normal part of treatment and what may need to be discussed at a follow-up visit.
- Reduced peripheral vision, which may in some cases affect the ability to pass driving vision tests
- Decreased night vision and greater difficulty adjusting to dim lighting
- Temporary blurriness or mild swelling of the macula (the central retina)
- Mild to moderate discomfort during or after sessions
- Rarely, a temporary increase in eye pressure or worsening of macular edema
Your retina specialist will monitor for these effects at follow-up visits and will adjust the treatment plan as needed to protect your vision.
PRP and Anti-VEGF Therapy
PRP is not the only treatment for proliferative diabetic retinopathy. Anti-VEGF injections have become an important part of how this condition is managed, and for many patients, the two treatments work best together.
Anti-VEGF medications work by blocking the VEGF protein directly, reducing its ability to stimulate abnormal blood vessel growth. These medications are injected into the eye in a quick, minimally uncomfortable procedure performed in our office. Commonly used anti-VEGF agents include aflibercept (Eylea), ranibizumab (Lucentis), bevacizumab (Avastin, used off-label for retinal conditions), and faricimab (Vabysmo). Injection schedules vary depending on the medication and how each patient responds, typically ranging from every four weeks to every several months.
A major clinical study known as Protocol S compared anti-VEGF therapy to PRP alone for proliferative diabetic retinopathy. The study found that anti-VEGF therapy performed at least as well as PRP for preserving vision, and patients receiving injections had less peripheral vision loss in the short term. However, anti-VEGF therapy requires ongoing injections, sometimes for years, to maintain its effect. PRP, once a full course is completed, provides a more durable result that does not depend on continued injection visits.
The decision between PRP, anti-VEGF therapy, or a combination depends on several individual factors. These include the severity of the disease, whether macular edema is also present, how reliably a patient can attend frequent injection appointments, and overall health. Your retina specialist will walk through the benefits and tradeoffs of each approach and build a plan suited to your specific situation.
Living Well After PRP
PRP is an important step in protecting your vision, but caring for your eye health does not stop at the laser. Long-term outcomes depend significantly on how well the underlying diabetes is managed day to day.
PRP treats the consequences of diabetic eye disease, but controlling the underlying diabetes is what slows the disease itself. Keeping blood sugar in a healthy range, managing blood pressure, and controlling cholesterol all help protect the retina from further damage. Working closely with your primary care doctor or endocrinologist on these goals directly supports the work we do to protect your vision.
Regular follow-up visits with your retina specialist are essential after PRP. During these visits, we check whether the abnormal blood vessels have regressed and whether additional laser sessions or other treatments are needed. Follow-up typically includes dilated exams and may include OCT imaging or fluorescein angiography. Some patients need additional PRP if neovascularization persists or returns. Others may need anti-VEGF injections if macular edema develops. Diabetic eye disease is a chronic condition that requires lifelong monitoring.
Because PRP can affect peripheral and night vision, some practical adjustments may be helpful after treatment. Using extra lighting when reading or working indoors can ease the change in low-light sensitivity. Being more cautious when driving at night and giving yourself extra time to adjust between bright and dim environments are also useful strategies. If peripheral vision loss raises questions about driving eligibility, your retina specialist can provide documentation and further guidance.
Frequently Asked Questions
Here are answers to questions our patients commonly ask about PRP laser treatment for diabetic eye disease.
Most patients feel a stinging or deep aching sensation during the procedure, and discomfort can increase as the session progresses. The level of pain varies considerably from person to person. If discomfort becomes significant during your session, let your specialist know right away. The laser settings can be adjusted, or the session can be paused to allow you to rest. Numbing drops are applied before treatment, and modern pattern-scanning lasers with shorter pulse durations are generally more comfortable than older techniques.
A complete course of PRP typically requires two to four sessions spaced one to two weeks apart, though the number depends on the extent of the disease and how your eye responds to treatment. Each session treats a portion of the peripheral retina. Some patients need additional sessions later if neovascularization does not fully regress or if it returns over time. Your retina specialist will assess your response after each visit and let you know whether further treatment is recommended.
Some reduction in peripheral and night vision is expected after PRP because the laser intentionally treats peripheral retinal tissue to reduce its oxygen demand. The degree of change depends on how much laser treatment is required to control the disease. For most patients, this tradeoff is worthwhile because PRP significantly reduces the risk of severe central vision loss or blindness from untreated proliferative diabetic retinopathy. If you have concerns about how vision changes may affect driving or daily activities, this is an important topic to discuss openly with your retina specialist before treatment begins.
Yes, and many patients benefit from using both treatments together. Anti-VEGF injections can quickly reduce active neovascularization and treat macular edema, while PRP provides a more lasting reduction in the retina's oxygen demand. The timing and sequence of these treatments is carefully tailored to each individual. Using them in combination does not complicate your care in a way you need to manage, and our specialists are experienced in guiding patients through combination treatment plans.
PRP is not a cure for diabetic eye disease and does not reverse damage that has already occurred. It is a treatment designed to stop or slow progression and reduce the risk of severe vision loss. Diabetic eye disease is a chronic condition that requires ongoing management. Even after a successful course of PRP, the retina needs to be monitored regularly. If blood sugar control worsens or the disease progresses, additional treatment may be needed over time.
PRP itself is a planned, office-based procedure rather than an emergency treatment. However, certain complications of proliferative diabetic retinopathy, such as vitreous hemorrhage (sudden bleeding inside the eye) or tractional retinal detachment, do require urgent or emergency care. If you experience a sudden increase in floaters, flashes of light, a curtain-like shadow across your vision, or sudden unexplained vision loss, do not wait for a scheduled appointment. Contact our office immediately or go to the nearest emergency room. Rapid evaluation in these situations can be vision-saving.
Visit New England Retina Associates for Expert Retina Care
If you have been diagnosed with diabetic eye disease or referred for PRP, our fellowship-trained vitreoretinal surgeons are here to help you understand your condition and your options. New England Retina Associates has provided specialized retinal care to patients across Connecticut for decades, combining deep clinical expertise with advanced diagnostic technology and a genuine commitment to each patient's long-term vision health. We welcome self-referred patients as well as those sent by their eye doctor or primary care provider, and we are here to guide you through every step of your care.
30 Years of Care & Commitment
